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Due to the COVID-19 pandemic, elective orthopedic proce-
dures are currently, to a great extent, postponed (CDC 2020, 
ECDC 2020). However, patients with and without COVID-19, 
with cancer, infections in bones, joints, and soft tissues, criti-
cal ischemia, open and unstable fractures, and other urgent 
diagnoses will still be in need of orthopedic surgery. 
It is widely accepted that healthcare workers (HCWs) per-
forming procedures involving the respiratory tract face a high 
risk of contracting Severe Acute Respiratory Syndrome Coro-
navirus 2 (SARS-CoV-2). This is reflected in the WHO’s rec-
ommendation (WHO 2020b) for the highest standard of per-
sonal protective equipment (PPE) in these cases. The risk for 
HCWs to contract SARS-CoV-2 during orthopedic surgery, or 
most other surgeries for that matter, has not been studied and 
is consequently less clear. 
Orthopedic surgery often involves the use of high-speed 
saws, power drills, pulsed lavage, suction, and electrocauteri-
zation. Shedding of droplets from the wound is reflected in 
the extensive use of protective eyewear, such as goggles and 
visor, in everyday practice. Concern amongst surgeons and 
other HCWs that otherwise rational precautionary principles 
are being set aside due to lack of scientific evidence and a 
shortage of PPE is obvious on social media platforms and 
amongst colleagues.
This short review is an attempt to translate relevant knowl-
edge into practical recommendations for HCWs involved 
in orthopedic surgery on patients with known or suspected 
COVID-19. 
Transmission of SARS-CoV-2
Virus shedding through droplets that rapidly fall to the ground 
requires a different PPE approach to prevent transmission than 
Background and purpose — COVID-19 is among the 
most impactful pandemics that the society has experienced. 
Orthopedic surgery involves procedures generating droplets 
and aerosols and there is concern amongst surgeons that oth-
erwise rational precautionary principles are being set aside 
due to lack of scientific evidence and a shortage of personal 
protective equipment (PPE). This narrative review attempts 
to translate relevant knowledge into practical recommenda-
tions for healthcare workers involved in orthopedic surgery 
on patients with known or suspected COVID-19.
Patients and methods — We unsystematically searched 
in PubMed, reference lists, and the WHO’s web page for rel-
evant publications concerning problems associated with the 
PPE used in perioperative practice when a patient is COVID-
19 positive or suspected to be. A specific search for literature 
regarding COVID-19 was extended to include publications 
from the SARS epidemic in 2002/3.
Results — Transmission of infectious viruses from 
patient to surgeon during surgery is possible, but does not 
appear to be a considerable problem in clinical practice. 
Seal-leakage is a problem with surgical masks. Due to the 
lack of studies and reports, the possibility of transmission 
of SARS-CoV-2 from patient to surgeon during droplet- and 
aerosol-generating procedures is unknown.
Interpretation — Surgical masks should be used only in 
combination with a widely covering visor and when a respi-
rator (N95, FFP2, P3) is not made available. Furthermore, 
basic measures to reduce shedding of droplets and aerosols 
during surgery and correct and consistent use of personal 
protective equipment is important.
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infectious aerosols that can remain airborne for a longer period. 
According to the WHO, the transmission of SARS-CoV-2 
mainly occurs through droplets (WHO 2020a). The organiza-
tion concludes that transfer through aerosols is unlikely except 
during specific aerosol-generating procedures. As a response, 
Nature problematized existing controversies regarding pos-
sible air-transmission in a news story, shedding light on the 
complexity of the subject and that several uncertainties cannot 
be clarified in a long time (Anon 2020). 
SARS-CoV-2 RNA (vRNA) has been found in aerosols 
(Ong et al. 2020, Santarpia et al. 2020). However, it is not 
clear whether aerosols contain infectious SARS-CoV-2, or 
enough viable virus to transmit the disease. We are not aware 
of any studies that have investigated aerosols produced during 
surgery on patients with SARS-CoV-2 viremia or dissemi-
nated disease. 
Presence of SARS-CoV-2 in the musculoskeletal 
system
SARS-CoV-2 was first identified in December 2019 and, con-
sequently, is not fully understood. Like SARS-CoV, the coro-
navirus causing the 2002/3 SARS epidemic, SARS-CoV-2 
binds to ACE2 receptors on human cells (Shang et al. 2020). 
ACE2 receptors are present on cells in the lungs and small 
intestines, but also on cells in a variety of other tissues, includ-
ing veins, arteries, and skeletal muscle, throughout the body 
(Hamming et al. 2004, Riquelme et al. 2014). 
Most current tests used to confirm the presence of SARS-
CoV-2 use PCR technology to detect vRNA. A vRNA test will 
return positive with viable virus, but also with non-viable virus 
and virus debris. Only a viable virus can infect new individu-
als. To our knowledge infectious virus has been found only in 
respiratory tract tissue and in 2 fecal samples from 8 patients 
(Wang et al. 2020, Wolfel et al. 2020). We are not aware of any 
published studies that have aimed to find viable SARS-CoV-2 
in blood, bone, bone marrow, or skeletal muscle in COVID-19 
patients. An in vitro study showed replication of SARS-CoV-2 
within blood-vessel organoids (Monteil et al. 2020). 
Several studies have identified vRNA in blood and serum 
(Shang et al. 2020, Wang et al. 2020, Young et al. 2020). vRNA 
has been found in both the severely ill and in patients with mild 
symptoms. Amongst 15 patients with multiple site samples, 
vRNA in blood was detected in 6 patients with negative swabs 
from the upper respiratory system (Zhang et al. 2020). 
An autopsy study including 8 deceased patients from the 
SARS epidemic in 2002/3 showed widespread virus dissemi-
nation in immune cells of the blood, spleen, and lymph nodes 
and in cells of the respiratory tract, renal tubules, intestines, 
and brain (Gu et al. 2005). Virus was not found within skeletal 
muscle cells. 
Aerosol formation during orthopedic surgery
High-speed saws, power-drills, pulsed lavage, suction, and 
electrocauterization are all droplet- and aerosol-generating 
procedures. Infected fluids, such as blood and irrigation fluid, 
can aerosolize during surgery and shed bacteria and viruses 
and have the potential to transmit disease (Heinsohn and 
Jewett 1993). 
During experimental set-ups in vivo, infectious HIV-1 parti-
cles have been found in aerosols produced using an oscillating 
saw on a known infected individual (Johnson and Robinson 
1991) and aerosols formed in laser fume transmitted disease in 
a bovine Papillomavirus model (Garden et al. 2002). Both the 
use of a high-speed cutter and pulsed lavage showed shedding 
of Staphylococcus aureus several meters from the operating 
field. The shedding was reduced, but not eliminated, when a 
drape was used as an overlying protective barrier (Nogler et al. 
2001, Putzer et al. 2017). Literature is sparse, and we could not 
find evidence of disease transmission from patient to surgeon 
through aerosolized virus-infected fluids from orthopedic-like 
procedures in clinical practice. 
Surgical masks and particulate respirators (N95, 
FFP2/P3)
Originally, surgical masks were made to protect the patient 
from infectious pathogens in HCWs. Respirators, the some-
what confusing technical term for face masks with the stan-
dards N95, FFP2/P3, were designed to protect the user from 
airborne particles. 
The WHO’s recommendations regarding PPE do not discuss 
aerosol-generating surgical procedures on infected patients 
(WHO 2020b). A review from the Norwegian Institute of 
Public Health (2020) concludes that evidence regarding the 
risk of aerosol transmission through aerosol-generating pro-
cedures, other than those directly or indirectly affecting the 
airways, is low. Respirators (N95, FFP2/P3), are consequently 
not recommended for open surgeries elsewhere in the body 
(WHO 2020b, FHI 2020). 
A randomized controlled clinical trial including 446 nurses 
concluded non-inferiority of surgical masks when compared 
with N95 respirators in preventing transmission of influ-
enza  and other respiratory viruses (coronavirus included) 
from patients to HCWs (Loeb et al. 2009). This finding from 
clinical practice has been supported by 3 later meta-analyses 
including approximately 9,000 subjects (Smith et al. 2016, 
Bartoszko et al. 2020, Long et al. 2020). All the included stud-
ies were performed in non-aerosol-generating settings. N95 
respirators were found to be superior to surgical masks under 
laboratory settings regarding filter penetration and face-seal 
leakage (Smith et al. 2016). Experience from the SARS epi-
demic stresses the importance of correct and consistent use 
of PPE and that this might be just as important as type of 
airway protection to prevent nosocomial disease transmission 
(Seto et al. 2003, Loeb et al. 2004). It must still be empha-
sized that data from the SARS outbreak in Toronto showed 
a trend in favor of N95 respirators over surgical masks for 
HCWs involved in respiratory tract procedures. The difference 
did not reach statistical significance, but the number of nurses 
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included was low for this sub-analysis (n = 20, 3 infected) 
(Loeb et al. 2004). 
Can virus transmission occur during orthopedic sur-
gery on patients with Covid-19?
COVID-19 is a new, harmful and rapidly spreading disease 
that first occurred less than 4 months ago, i.e., in December 
2019. The knowledge regarding the potential of SARS-CoV-2, 
and the previous SARS-CoV, to spread via droplets and aero-
sols produced during surgery is very sparse. 
Some patients with both mild and severe COVID-19 have 
vRNA in their blood indicative of viremia. Infectious disease 
transmission through both droplets and aerosols produced 
during orthopedic surgery is possible. In the case of SARS-
CoV-2, the risk naturally depends on the virus’s capability of 
transmission through tissues other than respiratory tract tis-
sues and feces. Results from possible investigations of such 
a capability have not been published at the time of writing 
(April 2020). 
Conclusions
The presence of viable virus in blood, bone marrow, or soft 
tissues has to our knowledge not yet been studied and should 
be addressed as soon as possible during this pandemic. 
Our following recommendations are based on available lit-
erature at the time of writing. The absence of evidence is, in 
situations like this, not a sufficient reason to restrict HCWs’ 
access to the PPE necessary to protect against transmission of 
a virus with the potential to cause a severe infection. 
The inferiority of surgical masks to respirators (P95, FFP2/
P3) during surgery on a COVID-19 patient is not so clear. 
Seal-leakage due to poor fit is a problem with surgical masks. 
Hence, surgical masks should only be used in combination 
with a widely covering visor and if a respirator (P95, FFP2, P3) 
is not made available. Furthermore, basic protective measures 
should be implemented, such as avoiding pulsed lavage and 
the use of power tools when possible, and covering the surgical 
field with a waterproof drape while performing droplet- and 
aerosol-generating procedures. Finally, correct and consistent 
use of PPE is of outmost importance for orthopedic surgeons in 
general, and, based on current literature, probably more impor-
tant than the use of respirators (P95, FFP2, P3) per se. 
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